186 related articles for article (PubMed ID: 31674105)
1. Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis.
Dueland S; Grut H; Syversveen T; Hagness M; Line PD
Am J Transplant; 2020 Feb; 20(2):530-537. PubMed ID: 31674105
[TBL] [Abstract][Full Text] [Related]
2. Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.
Dueland S; Syversveen T; Solheim JM; Solberg S; Grut H; Bjørnbeth BA; Hagness M; Line PD
Ann Surg; 2020 Feb; 271(2):212-218. PubMed ID: 31188200
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial.
Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study).
Smedman TM; Line PD; Hagness M; Syversveen T; Grut H; Dueland S
BJS Open; 2020 Jun; 4(3):467-477. PubMed ID: 32333527
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of
Grut H; Dueland S; Line PD; Revheim ME
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):218-225. PubMed ID: 29026950
[TBL] [Abstract][Full Text] [Related]
6. Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.
Grut H; Revheim ME; Line PD; Dueland S
Nucl Med Commun; 2018 Jul; 39(7):621-627. PubMed ID: 29683930
[TBL] [Abstract][Full Text] [Related]
7. Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
Dueland S; Hagness M; Line PD; Guren TK; Tveit KM; Foss A
Ann Surg Oncol; 2015 Jul; 22(7):2195-200. PubMed ID: 25297902
[TBL] [Abstract][Full Text] [Related]
8. Role of [
Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
[TBL] [Abstract][Full Text] [Related]
9. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
Serrano PE; Gu CS; Moulton CA; Gallinger S
Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573
[TBL] [Abstract][Full Text] [Related]
10. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?
Dueland S; Guren TK; Hagness M; Glimelius B; Line PD; Pfeiffer P; Foss A; Tveit KM
Ann Surg; 2015 May; 261(5):956-60. PubMed ID: 24950280
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for colorectal secondaries: on the way to validation.
Line PD
Curr Opin Organ Transplant; 2022 Aug; 27(4):329-336. PubMed ID: 36354259
[TBL] [Abstract][Full Text] [Related]
13. Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study.
Smedman TM; Guren TK; Line PD; Dueland S
Transpl Int; 2019 Nov; 32(11):1144-1150. PubMed ID: 31209941
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for nonresectable liver metastases from colorectal cancer.
Hagness M; Foss A; Line PD; Scholz T; Jørgensen PF; Fosby B; Boberg KM; Mathisen O; Gladhaug IP; Egge TS; Solberg S; Hausken J; Dueland S
Ann Surg; 2013 May; 257(5):800-6. PubMed ID: 23360920
[TBL] [Abstract][Full Text] [Related]
15. Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study.
Grut H; Line PD; Syversveen T; Dueland S
Ann Nucl Med; 2022 Dec; 36(12):1073-1081. PubMed ID: 36241941
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
Correa-Gallego C; Gavane S; Grewal R; Cercek A; Klimstra DS; Gewirtz AN; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N; D'Angelica MI
HPB (Oxford); 2015 Jul; 17(7):644-50. PubMed ID: 26010778
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D
Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615
[TBL] [Abstract][Full Text] [Related]
19. Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
Dueland S; Foss A; Solheim JM; Hagness M; Line PD
Br J Surg; 2018 May; 105(6):736-742. PubMed ID: 29532908
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
Detry O; Govaerts L; Deroover A; Vandermeulen M; Meurisse N; Malenga S; Bletard N; Mbendi C; Lamproye A; Honoré P; Meunier P; Delwaide J; Hustinx R
World J Gastroenterol; 2015 Mar; 21(10):3049-54. PubMed ID: 25780305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
